1. Home
  2. CLPT
  3. CLPT News

Latest ClearPoint Neuro Inc. (CLPT) News on November 28, 2025

CLPT

ACCESS Newswire

8 days ago

ClearPoint Neuro Completes Acquisition of IRRAS

Despite currently being unprofitable, ClearPoint Neuro (NASDAQ:CLPT) has delivered a 66% return to shareholders over 5 years
CLPT

Simply Wall St.

14 days ago

Despite currently being unprofitable, ClearPoint Neuro (NASDAQ:CLPT) has delivered a 66% return to shareholders over 5 years

Integra LifeSciences (IART) Q3 Earnings Beat Estimates
CLPT

Zacks

a month ago

Integra LifeSciences (IART) Q3 Earnings Beat Estimates

TransMedics (TMDX) Beats Q3 Earnings Estimates
CLPT

Zacks

a month ago

TransMedics (TMDX) Beats Q3 Earnings Estimates

CLPT

ACCESS Newswire

2 months ago

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

CLPT

ACCESS Newswire

2 months ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
CLPT

Zacks

2 months ago

CLPT Expands Into Robotic System Supporting Cell and Gene Therapies

ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress
CLPT

Simply Wall St.

2 months ago

ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
CLPT

ACCESS Newswire

2 months ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
CLPT

Insider Monkey

6 months ago

ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory

Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
CLPT

TipRanks

6 months ago

Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint

ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
CLPT

Simply Wall St.

6 months ago

ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
CLPT

GuruFocus.com

6 months ago

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges

CLPT

ACCESS Newswire

6 months ago

ClearPoint Neuro Reports First Quarter 2025 Results

CLPT

ACCESS Newswire

7 months ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look For
CLPT

GuruFocus.com

7 months ago

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look For

CLPT

ACCESS Newswire

7 months ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing
CLPT

Simply Wall St.

7 months ago

The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing

CLPT

ACCESS Newswire

7 months ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

CLPT

ACCESS Newswire

7 months ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Here's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn Situation
CLPT

Simply Wall St.

8 months ago

Here's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn Situation

ClearPoint Neuro Full Year 2024 Earnings: Misses Expectations
CLPT

Simply Wall St.

9 months ago

ClearPoint Neuro Full Year 2024 Earnings: Misses Expectations

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Analysts Are Pretty Bullish On The Stock After Recent Results
CLPT

Simply Wall St.

9 months ago

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Analysts Are Pretty Bullish On The Stock After Recent Results

CLPT

ACCESS Newswire

9 months ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings
CLPT

GuruFocus.com

9 months ago

ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings

While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership
CLPT

Simply Wall St.

9 months ago

While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership

CLPT

ACCESS Newswire

9 months ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

CLPT

ACCESS Newswire

10 months ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

ClearPoint Neuro price target raised to $20 from $15 at B. Riley
CLPT

TipRanks

10 months ago

ClearPoint Neuro price target raised to $20 from $15 at B. Riley

ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
CLPT

Insider Monkey

10 months ago

ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory

CLPT

ACCESS Newswire

10 months ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
CLPT

ACCESSWIRE

a year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
CLPT

Simply Wall St.

a year ago

The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

CLPT

ACCESSWIRE

a year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect
CLPT

GuruFocus.com

a year ago

ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213%
CLPT

Simply Wall St.

a year ago

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213%

CLPT

ACCESSWIRE

a year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
CLPT

GlobeNewswire

a year ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

ClearPoint Neuro Announces Early Repayment of $10 Million Note
CLPT

GlobeNewswire

a year ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

ClearPoint Neuro Reports Second Quarter 2024 Results
CLPT

GlobeNewswire

a year ago

ClearPoint Neuro Reports Second Quarter 2024 Results

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
CLPT

GlobeNewswire

a year ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
CLPT

GlobeNewswire

a year ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
CLPT

PR Newswire

a year ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
CLPT

GlobeNewswire

a year ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

CLPT

GuruFocus.com

2 years ago

ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...

ClearPoint Neuro Reports First Quarter 2024 Results
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Reports First Quarter 2024 Results

ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?
CLPT

Simply Wall St.

2 years ago

Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year
CLPT

Simply Wall St.

2 years ago

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year

ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations
CLPT

Simply Wall St.

2 years ago

ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations

CLPT

GuruFocus.com

2 years ago

ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
CLPT

GlobeNewswire

2 years ago

Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

ClearPoint Neuro Launches Proposed Public Offering of Common Stock
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
CLPT

CNW Group

2 years ago

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

Adams Diversified Equity Fund Announces 2023 Performance
CLPT

GlobeNewswire

2 years ago

Adams Diversified Equity Fund Announces 2023 Performance

Adams Diversified Equity Fund Declares Distribution
CLPT

GlobeNewswire

2 years ago

Adams Diversified Equity Fund Declares Distribution

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS
CLPT

CNW Group

2 years ago

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

Nanox Mourns Death of Its Founder, Ran Poliakine
CLPT

GlobeNewswire

2 years ago

Nanox Mourns Death of Its Founder, Ran Poliakine

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

L.B. Foster's (NASDAQ:FSTR) investors will be pleased with their respectable 93% return over the last year
CLPT

Simply Wall St.

2 years ago

L.B. Foster's (NASDAQ:FSTR) investors will be pleased with their respectable 93% return over the last year

CLPT

Associated Press Finance

2 years ago

Concrete Pumping: Fiscal Q4 Earnings Snapshot

Concrete Pumping Holdings Reports Strong Fourth Quarter and Fiscal Year 2023 Results, Provides Financial Outlook for Fiscal Year 2024
CLPT

GlobeNewswire

2 years ago

Concrete Pumping Holdings Reports Strong Fourth Quarter and Fiscal Year 2023 Results, Provides Financial Outlook for Fiscal Year 2024

Similarweb Reveals 100 Digital Businesses That Achieved Outstanding Growth in 2023
CLPT

Business Wire

2 years ago

Similarweb Reveals 100 Digital Businesses That Achieved Outstanding Growth in 2023

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
CLPT

GlobeNewswire

2 years ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS
CLPT

GlobeNewswire

2 years ago

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

Thornburg Income Builder Opportunities Trust Announces Distribution
CLPT

PR Newswire

2 years ago

Thornburg Income Builder Opportunities Trust Announces Distribution

Unity Bancorp (NASDAQ:UNTY) shareholders have earned a 21% CAGR over the last three years
CLPT

Simply Wall St.

2 years ago

Unity Bancorp (NASDAQ:UNTY) shareholders have earned a 21% CAGR over the last three years

Calavo Growers Insiders Placed Bullish Bets Worth US$4.98m
CLPT

Simply Wall St.

2 years ago

Calavo Growers Insiders Placed Bullish Bets Worth US$4.98m

Sharecare to present at 42nd Annual J.P. Morgan Healthcare Conference
CLPT

GlobeNewswire

2 years ago

Sharecare to present at 42nd Annual J.P. Morgan Healthcare Conference

While insiders own 32% of Backblaze, Inc. (NASDAQ:BLZE), retail investors are its largest shareholders with 37% ownership
CLPT

Simply Wall St.

2 years ago

While insiders own 32% of Backblaze, Inc. (NASDAQ:BLZE), retail investors are its largest shareholders with 37% ownership

We're Keeping An Eye On Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate
CLPT

Simply Wall St.

2 years ago

We're Keeping An Eye On Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate

Invivyd (IVVD) Surges on Positive Data From COVID-19 Study
CLPT

Zacks

2 years ago

Invivyd (IVVD) Surges on Positive Data From COVID-19 Study

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%
CLPT

Simply Wall St.

2 years ago

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%

Skeena Closes C$81 Million Financing with Franco-Nevada
CLPT

ACCESSWIRE

2 years ago

Skeena Closes C$81 Million Financing with Franco-Nevada

Julie Casteel Wins Stevie® Award for Women in Business
CLPT

GlobeNewswire

2 years ago

Julie Casteel Wins Stevie® Award for Women in Business

Is There Now An Opportunity In Entravision Communications Corporation (NYSE:EVC)?
CLPT

Simply Wall St.

2 years ago

Is There Now An Opportunity In Entravision Communications Corporation (NYSE:EVC)?

11 Best Water Stocks To Buy
CLPT

Insider Monkey

2 years ago

11 Best Water Stocks To Buy

Stablewood and GCM Grosvenor Form Joint Venture to fund Single Tenant Net Lease Retail Developments Across the U.S.
CLPT

GlobeNewswire

2 years ago

Stablewood and GCM Grosvenor Form Joint Venture to fund Single Tenant Net Lease Retail Developments Across the U.S.

Multiple Grammy Award-Winning Artist Luis Miguel Partners with Alignment Health to Champion Living with Confidence
CLPT

GlobeNewswire

2 years ago

Multiple Grammy Award-Winning Artist Luis Miguel Partners with Alignment Health to Champion Living with Confidence

Alpha Tau to Participate in Sidoti Small-Cap Conference
CLPT

GlobeNewswire

2 years ago

Alpha Tau to Participate in Sidoti Small-Cap Conference

CITIC Offshore Helicopter and Lilium partner to launch eVTOL Network in China's Greater Bay Area
CLPT

GlobeNewswire

2 years ago

CITIC Offshore Helicopter and Lilium partner to launch eVTOL Network in China's Greater Bay Area

Are Investors Undervaluing ClearPoint Neuro, Inc. (NASDAQ:CLPT) By 41%?
CLPT

Simply Wall St.

2 years ago

Are Investors Undervaluing ClearPoint Neuro, Inc. (NASDAQ:CLPT) By 41%?

Akebia Therapeutics to Present at Piper Sandler Healthcare Conference
CLPT

PR Newswire

2 years ago

Akebia Therapeutics to Present at Piper Sandler Healthcare Conference

One Analyst Just Shaved Their Magic Software Enterprises Ltd. (NASDAQ:MGIC) Forecasts Dramatically
CLPT

Simply Wall St.

2 years ago

One Analyst Just Shaved Their Magic Software Enterprises Ltd. (NASDAQ:MGIC) Forecasts Dramatically

CLPT

Associated Press Finance

2 years ago

Magic Software: Q3 Earnings Snapshot

American Coastal Insurance Corporation Reports Financial Results for Its Third Quarter Ended September 30, 2023
CLPT

Business Wire

2 years ago

American Coastal Insurance Corporation Reports Financial Results for Its Third Quarter Ended September 30, 2023

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript
CLPT

Insider Monkey

2 years ago

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript

ClearPoint Neuro Reports Third Quarter 2023 Results
CLPT

GlobeNewswire

2 years ago

ClearPoint Neuro Reports Third Quarter 2023 Results

Share on Social Networks: